Rubella Virus Vaccine

Recommendation on Immunization Practices: A Prelicensing Statement

Excerpt

The live, attenuated rubella virus vaccine* soon to become available appears to be a highly effective immunizing agent and the first suitable method of controlling rubella.

Rubella is generally a mild illness, but if the infection is acquired by a woman in the early months of pregnancy it poses a direct hazard to the fetus. Preventing infection of the fetus is the principal objective of rubella control. This can best be achieved by eliminating the transmission of virus among children, who are the major source of infection for susceptible pregnant women. The live, attenuated rubella virus vaccine is safe and

This 100-word excerpt has been provided in the absence of an abstract.

Article and Author Information

  • Official name: Rubella Virus Vaccine, Live.

« Previous | Next Article »Table of Contents